Chantix warnings from FDA
Full Story
| News Archive
| Topics: FDA, pharmaceutical, suicide
People taking Chantix, a drug to stop smoking, have reported suicidal thoughts, and mood changes including erratic and aggressive behavior, leading the FDA to issue a warning to patients and health care providers. Pfizer is working with the FDA to supply additional pertinent information.
Nearly two-thirds of all people with a mental illness smoke -- far greater than the rest of the population -- and targeted campaigns have addressed this health hazard in hospital and community settings. Complaints also came from people without a pre-existing psychiatric condition.
